Overview
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.
Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
Description
none considered needed
Eligibility
Inclusion Criteria:
- newly diagnosed IBD
Exclusion Criteria:
- previous IBD with specific treatment within 10 year
- inability to consent
- inability to adhere to treatment protocol